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Focal segmental glomerulosclerosis associated with mitochon- lar disorders were the first to be studied, and direct evi-
drial cytopathy. dence of mitochondrial DNA (mtDNA) abnormalities
Background. The nonspecific lesion of focal segmental glo-
was demonstrated as early as 1988 [1, 2]. These clinicalmerulosclerosis (FSGS) can occur as a primary disease or in
manifestations are the consequences of cellular defectsa variety of secondary settings. In mitochondrial cytopathies
(MCs), the phenotypic expression of the disease depends on in oxidative phosphorylation and adenosine 59-triphos-
the degree of cellular dysfunction, and this correlates with the phate (ATP) production by mitochondria, and depend
proportion of abnormal mitochondrial DNA in the cells and
on the proportion of abnormal mtDNA in the cells andthe dependence of tissues on oxidative metabolism. The most
the dependence of each tissue on oxidative metabolism.common renal manifestation in MCs is tubular dysfunction;
little has been reported about glomerular diseases. Until recently, MCs were considered to be rare; renal
Methods. Cases of four adult patients with FSGS and MC are manifestations of MCs were considered to be restrictedreported. Routine histology and mitochondrial DNA analysis
to childhood. The most common renal clinical presenta-were carried out on renal biopsies.
Results. Family history and clinical manifestations in the tion of MCs is tubular dysfunction [3]. In adults, progres-
four patients with FSGS suggested a diagnosis of MC. An sive renal failure has recently been reported [4], and a
A3243G transition in the mitochondrial DNA tRNAleu(UUR) was
number of childhood cases of focal segmental glomerulo-found in lymphocytes and kidney. Glomerular lesions of FSGS
sclerosis (FSGS) have also been reported [5–7]. Thiswere associated with unusual hyaline lesions, which appeared
to represent individual myocyte necrosis in afferent arterioles nonspecific glomerular lesion, which accounts for 20% of
and small arteries. all nephrotic syndromes in adults, can occur as a primary
Conclusion. FSGS is a renal manifestation of MCs. The re-
disease or in a variety of secondary settings. FSGS ap-nal lesion can precede other manifestations of the genetic dis-
pears to be the immediate consequence of a primary orease by many years. The striking arteriolar lesions in these
cases may have resulted in glomerular hypertension and hyper- secondary visceral glomerular epithelial cell defect or
perfusion, leading to secondary epithelial cell abnormalities injury [8–10]. It is associated in many situations with
and, ultimately, FSGS. However, primary epithelial cell dys-
glomerular hypertension and hyperperfusion [11, 12].function caused by mitochondrial defects could not be ruled
We report the association of MC and FSGS in four adultsout on morphological grounds. MCs should be considered in
cases of so-called primary FSGS, particularly if there is a famil- and suggest the role of this cellular dysfunction, which
ial history of diabetes, neuromuscular disorders, or deafness. is of genetic origin, in the causation of the glomerular
lesion.
Clinical manifestations of mitochondrial cytopathies
(MCs) can affect almost all organ systems. Neuromuscu-
METHODS
We report the cases of four patients in three unrelated
Key words: lesion, cellular dysfunction, oxidative metabolism, tubular
families: A, B, and C. The patients were referred to onedysfunction, hyaline lesions, necrosis, hypertension.
of our nephrology units with a clinical history of chronic
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Case 1 proteinuria of between 0.5 and 1 g/24 hours. She was
known to have insulin-dependent diabetes from the ageThis white female was referred when she was 21 years
of 22. She was in good medical condition and had noold for a persistently high level of proteinuria (3.3 g/
sign of diabetic microangiopathy. Her blood pressure24 hours) three months after her second delivery. She
was normal, the creatinine level was 0.9 mg/dL, and shehad never had medical problems except for occasional
had no hematuria. Tubular function was not studied. Alow-grade proteinuria in childhood. A first renal biopsy
percutaneous renal biopsy was performed.was performed, but because of the presence of postpar-
Proteinuria had been discovered during her first preg-tum endothelial lesions in this biopsy and persisting pro-
nancy at the age of 23. This pregnancy and the next oneteinuria (5.08 g/24 hours) nine months later, a second
at the age of 24 were complicated by eclampsia withbiopsy was performed. At that time, she had normal blood
nephrotic syndrome and fetal loss. Deafness appearedpressure, no hematuria, and no sign of Fanconi or distal
when she was 29 years old. Figure 2 shows the pedigreetubular acidosis; her creatinine level was 0.5 mg/dL.
of family B.Her three pregnancies at ages 18, 20, and 26 were
complicated by a pre-eclamptic–like syndrome at the Case 4
end of the third month of each pregnancy. The first two
This white female was referred to the nephrology unitpregnancies produced two girls at 38 and 32 weeks of
for transplantation when she was 34 years old. She hadgestation; the last pregnancy was complicated by fetal
had permanent proteinuria since the age of 18, and herdeath.
only pregnancy at the age of 27 was complicated by pre-Proteinuria disappeared after the first delivery and per-
eclamptic–like syndrome and fetal death. Renal functionsisted after the second. Corticosteroid therapy (1 mg/kg)
began to deteriorate, and a percutaneous renal biopsywas given after the second biopsy and was then progres-
was performed when she was 32 years old. She requiredsively tapered and stopped six months later without any
hemodialysis at the age of 33. Clinical manifestationschange in proteinuria.
that pointed to the diagnosis of MC occurred after trans-Deafness was recognized when she was 28 years old,
plantation. She complained of muscular weakness onenecessitating a hearing aid one year later. Non–insulin-
year after transplantation. Non–insulin-dependent dia-
dependent diabetes occurred when she was 33 years old.
betes occurred at the age of 36. Cerebellar syndrome
Insulin therapy was introduced one year later. At that
occurred at the age of 37, and hearing loss was present
time, she had no sign of diabetic retinopathy on ophthal- at the age of 38. No family history was available.
moscopy, but macular pattern dystrophy was seen. Blood Kidney disease was detected in all of these patients
pressure increased, and renal function began to worsen at a mean age of 19.7 years (18 to 23 years). The ages
at age 34, requiring hemodialysis when she was 38 years of occurrence of successive clinical manifestations are
old. She received a renal transplant at the age of 40. shown in Table 1. Proteinuria remained the only clinical
symptom over 9, 22, and 17 years in cases 1, 2, and 4,Case 2
respectively. Diabetes was discovered 15 and 18 years
Isolated proteinuria was discovered in the brother of after kidney disease in cases 1 and 4, respectively. Renal
the first patient by the army medical board when he was biopsies were performed a considerable time before dia-
18, but was never explored. At that time, he did not betes developed in cases 1 and 4. In case 3, non–insulin-
have other medical problems. He was referred to the dependent diabetes was discovered one year before renal
nephrology unit at the age of 40. His proteinuria level disease developed. In the three females, renal disease
was 2.76 g/24 hours; he had normal blood pressure and was complicated by pre-eclamptic–like syndrome during
no hematuria, and his creatinine clearance was 80 mL/min. pregnancies and persisting proteinuria after pregnancies.
He had no signs of tubular dysfunction. A percutaneous As shown on the pedigrees, diabetes mellitus and/or
renal biopsy was performed. Although he was not known sensineural dysfunction was present on the maternal side
to be diabetic by his general practitioner, fasting and in families A and B.
postprandial blood glucose levels (150 and 240 mg/dL,
Methodsrespectively) suggested an impaired glucose tolerance.
Fluorescein angiography showed bilateral macular pat- The renal biopsies were divided for routine histology
tern dystrophy with normal retinal vessels. He had no and immunofluorescence studies, performed on tissue
sensineural hearing loss. The patient was lost to follow- fixed in Duboscq-Brazil fixative and on frozen tissue,
up. Figure 1 shows the pedigree of family A. respectively. A sample of the biopsy from one patient
was fixed in cacodylate-buffered glutaraldehyde and was
Case 3 processed for EM.
This Caucasian female was referred to the nephrology DNA analyses were performed on blood samples on
the patients and their relatives who agreed to be testedunit when she was 32 years old to explore permanent
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Fig. 1. Pedigree of family A. The symbols for
all individuals tested for A3243G transition
in the mitochondrial DNA tRNAleu(UUR) gene
are shown, and the proportion of mutated
mtDNA in blood is indicated in this article.
The proportion of mtDNA in kidney tissue,
when measured, is indicated to the right of the
proportion of mtDNA in blood. An asterisk
indicates individuals who have undergone re-
nal biopsy. Intrauterine fetal deaths (IUFD)
are indicated. Symbols are: , proteinuria; ,
deafness; , diabetes.
Fig. 2. Pedigree of family B. The symbols of
all individuals tested for A3243G transition
in the mitochondrial DNA tRNAleu(UUR) gene
are shown, and the proportion of mutated
mtDNA in blood is indicated in this article.
The proportion of mtDNA in kidney tissue is
indicated to the right of the proportion of
mtDNA in blood. An asterisk indicates the
individual who has undergone renal biopsy.
Intrauterine fetal death (IUFD) is indicated.
Symbols are: , proteinuria; , deafness; ,
diabetes.
Table 1. Clinical history of disease progression
Proteinuria Renal Hearing Muscular
(permanent) Pre-eclampsia biopsy Diabetes loss weakness HD TR
First symptom Age years
Case 1 Pre-eclampsia 18 years old 12 0 13 115 110 — 120 122
Case 2 Proteinuria (permanent) 18 years old 0 NAa 122 122 — — — —
Case 3 Diabetes 23 years old 11 11 110 0 17 — — —
Case 4 Proteinuria (permanent) 18 years old 0 19 114 118 120 117 115 116
The first symptoms and the patient’s age at their occurrence are shown. The remaining data show the periods in years between these first symptoms and other
clinical events. If another symptom was identified at the same time as the first one, the delay is zero years.
Abbreviations are: HD, hemodialysis; TR, transplantation; NA, not applicable.
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Fig. 3. Case 1. Glomerulus showing advanced lesions of segmental
sclerosis, with dark-staining hyalinosis lesion at right. Masson trichrome Fig. 4. Case 2. Arteriolar hyaline lesions involving individual smooth
3250. muscle cells (arrows), two in outer portion of wall, one more centrally
located. The glomerulus shows marked dilation of the hilus and of
numerous capillary loops. Masson trichrome 3400.
and on frozen kidney tissue for two of the patients. The
high frequency of diabetes in the pedigrees focused at-
definite hyalinosis lesions, although the other lesions oftention on a possible A3243G transition in the mtDNA
FSGS were present. In case 4, the lesions were extremelytRNAleu(UUR) gene.
advanced, nearly end stage; 15 of the 19 glomeruli pres-The A3243G transition in the mtDNA tRNAleu(UUR)
ent were totally sclerotic, with recognizable hyalinosisgene was examined using an allele-specific amplification
lesions in five of them. There was no suggestion of dia-technique that included polymerase chain reaction
betic changes.(PCR) amplification, agarose gel electrophoresis, and
Tubules in all cases showed at least focal atrophy,ethidium bromide staining. The primers used were the
together with variable interstitial fibrosis. Interstitial in-3243 common primer, 3243 wild-type primer, and 3243
flammatory infiltrates were generally minimal.mutant primer leading to a 185 bp fragment. A PCR
All biopsies showed very considerable lesions in thereaction was performed for each allele. Two internal
afferent arterioles. In case 2, the lesions were particularlycontrol primers were systematically added to the allele-
striking and clearly affected individual smooth musclespecific reaction leading to a 140 bp control fragment
cells, with the adjacent cells uninvolved (Fig. 4). Theand a 585 bp fragment corresponding to an amplification
involved cells showed hyaline cytoplasmic condensation,between the control primer and an allele-specific primer.
appearing to represent a form of coagulative necrosis orIn parallel, allele-specific PCR products were stained by
apoptosis. This pattern resembled the smooth musclethe PicoGreen reagent and were quantitated by fluo-
lesions observed in cyclosporine nephropathy. Cases 1,rimetry [13].
3, and 4 showed similar hyaline smooth muscle lesions
to those in case 2, but to a lesser degree.
RESULTS The interlobular arteries in two patients had the same
hyaline lesions of individual smooth muscle cells (Fig.Five renal biopsies were available for study from the
four patients. Biopsies from all four patients revealed 5). Medial scarring was observed in all of the vessels
examined in all five biopsies. However, in case 2, thereFSGS lesions on the initial biopsy, with a number of
glomeruli showing: a mesangial increase, particularly were small nodules of dense fibrous tissue in the media
in a pattern that suggested that they represented thenear the hilum; thickening of the perihilar capillaries,
with adhesions between these capillaries and Bowman’s residues of individual smooth muscle necrosis. Most ar-
teries showed no intimal fibroplasia, but there were sev-capsule; and typical podocyte changes. In at least two of
the viable glomeruli in each of the initial biopsies, there eral vessels with marked cellular intimal fibroplasia in
case 1. In case 2, two arterioles had definite hyalinewere typical hyalinosis lesions (Fig. 3), as well as intra-
capillary accumulations of hyaline material starting in mural thrombi partially occluding the lumen, resembling
platelet thrombi.the subendothelial region. The glomeruli of cases 1, 2,
and 3 were normal to enlarged in size, and all had widely Immunofluorescence was largely uniformative since
two specimens contained no glomeruli. One biopsy frompatent capillary loops, with distention of the hilar and
peripheral capillaries particularly marked in case 2. In case 1 revealed scattered grains of C3 only in the glomer-
uli. The biopsy from case 2 showed striking deposits ofthe second biopsy performed on case 1, there were no
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trophy suggested the involvement of apparently unre-
lated organ systems [14, 15]. Maternal inheritance of
diabetes and deafness in two families prompted mtDNA
analysis, focusing on the A3243G transition in the
mtDNA tRNAleu(UUR) gene. This point mutation is the
most frequent in mitochondrial diabetes [16] and is also
found in mitochondrial encephalomyopathy, lactic aci-
dosis, and stroke-like episodes syndrome (MELAS).
The possible pathogenesis of the FSGS in our cases
is of interest. Pregnancies may have triggered and/or
worsened the FSGS [17, 18]. Clinical manifestations of
renal disease occurred or became apparent and wor-
sened in the three females with successive pregnancies.
Pre-existing proteinuria in two cases and persisting renal
Fig. 5. Case 2. Two hyaline, presumably necrotic, smooth muscle cells disease a long time after delivery in all three cases suggest
(arrows) in wall of interlobular artery. Masson trichrome 3400. that if pregnancy had played a role in the condition, it
might have aggravated, rather than initiated, the process.
Diabetes as the underlying cause of FSGS can also be
eliminated in our cases. Glomerular hyalinosis lesionsC3 in the arterial and arteriolar walls, which appeared
of the sort seen in FSGS do indeed occur in diabetes,to correspond with the hyaline deposits described pre-
but when they are due to diabetes, they always appearviously in this article.
in a setting of frank diabetic nephropathy that is usuallyOne specimen was fixed and prepared for electron
fairly advanced [19]. The association of FSGS and earlymicroscopy (EM), but unfortunately contained only me-
lesions of diabetic glomerulopathy in a patient with MCdulla. No mitochondrial abnormalities were identified
has been reported, but evidence of the cause and effectin these tubules. Subsequently, deparaffinized material
relationship between FSGS and diabetes could not befrom four biopsies was embedded for EM. These prepa-
obtained [20]. In our cases, proteinuria occurred morerations were not satisfactory to examine the mitochon-
than 10 years before diabetes in three patients. Renaldria. They did allow the possibility of diabetic basement
biopsy was performed 6 and 12 years before diabetes inmembrane changes to be ruled out and confirmed the
cases 1 and 4. There was no histologic change of diabeticsmooth muscle location of the hyaline lesions.
nephropathy in the five biopsies. We were able to confirmDNA analysis showed the A3243G transition in the
these results by means of an EM on deparaffinized sec-mtDNA tRNAleu(UUR) gene in the lymphocytes of the four
tions. No other known urologic or metabolic predispos-probands and their relatives, as well as in the two kidneys
ing factors of FSGS could be found. A direct relationshipstudied (cases 2 and 3). Quantitative evaluation of wild-
between MC and FSGS remains the most likely explana-type and mutant mtDNA in the first three cases demon-
tion.strated that the proportion of mutant mtDNA varied
The deleterious cellular effects and the clinical mani-between 42 and 66% in lymphocytes. A higher propor-
festations in MCs due to mtDNA mutation occur whention of mutant mtDNA was observed in kidney tissue
the proportion of mutant mtDNA in the cells reaches a(15%) from cases 2 and 3 compared with lymphocytes.
threshold level [15]. This threshold effect varies from
person to person and from tissue to tissue, according to
DISCUSSION the dependence of each tissue on oxidative metabolism,
and can be influenced by epigenetic factors such as ageWe report the association of FSGS with MC in four
and sex [21, 22]. In an experimental model, the loss ofpatients from three unrelated families. Two characteris-
translational competency is reached when the proportiontics make these cases very unusual. First, MC and renal
of mutated mtDNA increases above 60% [23]. In ourdisease were discovered in adulthood, as opposed to
patients, the proportions of abnormal mtDNA found inchildhood as in previously described FSGS-related MC
kidney tissue in cases 2 and 3 were 55 and 66%, respec-[3–7]; renal disease preceded the clinical manifestations,
tively. The late onset of symptoms in our patients maywhich led to the diagnosis of MC in three patients. Sec-
reflect an initially milder abnormality in mtDNA. Theond, the renal lesions were typical of the appearance of
threshold level may have been reached secondarilyFSGS, but were associated with a peculiar vasculopathy.
[15, 24]. This is consistent with the frequent worseningThe diagnosis of MC was suspected when, in addition
of initial symptoms and the known increasing numberto the kidney disease, clinical symptoms such as diabetes,
hearing loss, muscle weakness, or macular pattern dys- of affected organs during the course of mitochondrial
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diseases and may explain the frequent involvement of malities, including multinucleation by light microscopy
and abnormal mitochondria by EM in patients withthe nervous system in the late stages of the disease [25].
The fact that kidney involvement was the first sign of FSGS and MELAS (abstract; J Am Soc Nephrol 9:90A,
1998). However, these have not been described by otherthe disease in these cases is compatible with the clinical
heterogeneity of MCs. The proportion of mutated authors reporting on EMs of glomerular lesions [7, 20].
In our cases, multinucleated glomerular epithelial cellsmtDNA in each cell is the result of the random segrega-
tion of mtDNA molecules at cell division. This observa- were definitely not present, but mitochondrial abnormal-
ities could not be found because of the lack of suitabletion also explains the different phenotypes of the disease
observed within the same family [15]. EM specimens. Metabolic mitochondrial dysfunction in
epithelial cells remains a possible explanation for theSeveral renal diseases, most often childhood condi-
tions, have been reported in which MCs caused by vari- proteinuria and glomerular sclerosis observed in our
patients.ous genomic abnormalities of mtDNA were implicated
[3, 5–7, 22]. Extrarenal lesions were described in all of However, the vascular lesions, which were so striking
in case 2 and present to a lesser degree in the otherthese patients. The most common renal manifestations
were the consequence of tubular cell dysfunction. Clini- cases, offer an alternative explanation for the glomerular
lesions that are more consistent with the vascular lesionscal symptoms were those of the de Toni-Debre-Fanconi
syndrome or tubulointerstitial nephritis. More rarely, re- in other MCs. These arterial and arteriolar lesions differ
from more typical hyaline arteriolosclerosis.nal tubular acidosis, Bartter-like syndrome, or hypercal-
ciuria may occur [3, 22, 26]. On ultrastructural examina- Arterial and arteriolar lesions similar to those in our
cases have been observed in other MCs [29–33]. Intion, abnormalities in mitochondrial number, size, and
configuration were seen in proximal tubules [7, 26]. A MELAS, lesions of the pial arterioles and small arteries
similar in the photographs to the lesions in our casesfew cases of FSGS in childhood with nephrotic syndrome
have also been reported [5–7]. have been described. They consist of smooth muscle cells
crammed with enlarged and abnormal mitochondria, al-In adults, cases of renal diseases in MC have been
reported. Chronic renal failure with diabetes and deaf- ternating with smooth muscle cells showing pyknosis and
shrinkage [31]. Three other studies have demonstratedness, secondarily related to MELAS syndrome, in four
patients was reported by Jansen et al [4]. In this report, similar arteriolar lesions in the striated muscle in
MELAS [29, 32] and myoclonic epilepsy and raggedchronic renal failure occurred after a mean period of
seven years. In two of our patients, renal failure occurred red fibers (MERFF) [30]. In one of these studies, these
lesions were shown to be extremely rich in succinate14 and 15 years after the first renal symptoms. In the
other two patients, kidney function remained normal 8 dehydrogenase, attesting to the density of mitochondria
in these cells [29]. Finally, similar smooth muscle cellsand 22 years after the first renal symptoms developed.
Renal failure was also reported in three previously dia- crammed with mitochondria alternating with smooth
muscle cells of normal appearance have been observedbetic patients with A3243G transition in the mtDNA
tRNAleu(UUR) [20]. In one patient of each of these reports, in the renal arterioles of an 11-year-old patient with
FSGS [7]. It seems extremely likely, despite the lack ofFSGS was described as the underlying lesion. In the
report by Jansen et al, slides from the patient with FSGS electron microscopic confirmation, that the arteries and
arterioles in our patients manifest the same lesions in awere not available for subsequent review. Familial
screening identified proteinuria in the son of one female more advanced state.
The arteriolar lesions in our patients may have beenwith chronic renal failure, and the renal lesions seen by
EM were consistent with primary lesions of FSGS [4]. responsible for diminution or abolition of the autoregu-
latory mechanisms by which glomerular pressure is main-In the second report, FSGS was associated with diabetic
glomerulosclerosis as we described previously in this arti- tained at a constant level over a wide range of systemic
pressures, and which lead to glomerular hypertension,cle [20].
In experimental models, the most important proxi- an increase in glomerular filtration rate and, eventually,
to the development of FSGS [33, 34].mate cause of FSGS is as yet poorly defined damage to
the glomerular podocytes; it is thought likely that a simi- The role of the loss of autoregulation in potentiating
glomerular lesions is increasingly recognized. The losslar process is the cause in humans [8–10]. In secondary
forms of FSGS that occur as a result of nephron reduc- of autoregulation has been identified at the clinical level
in diabetes [33] and in other glomerular diseases [35],tion, glomerular hypertrophy, with increased capillary
pressure and resulting hyperfiltration as well as increased and has been invoked in the progression of hypertensive
glomerular lesions [36]. In all of these conditions, mosttension on the mesangium, is a contributing element to
glomerular epithelial damage, mesangial increase, and particularly in diabetes, lesions consistent with secondary
FSGS can be recognized. Vascular lesions capable ofeventual sclerosis [11, 12, 27, 28].
Hotta et al describe glomerular epithelial cell abnor- leading to loss of autoregulation have long been recog-
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11. Rennke HG, Klein PS: Pathogenesis and significance of nonpri-ber of cases with secondary FSGS [39, 40]. The possibility
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12. Cortes P, Riser B, Narins RG: Glomerular hypertension andpreviously invoked in MCs [7, 20]. We suggest more
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248, 1995
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Y, Tanabe Y, Sakura H, Awata T, Goto Y, Hayakawa T, Matsu-
glomerular lesion and MC that we describe in this article oka K, Kawamori R, Kamada T, Horai S, Nonaka I, Hagura R,
Akanuma Y, Yazaki Y: A subtype of diabetes mellitus associatedraises the problem of the relationship between mitochon-
with a mutation of mitochondrial DNA. N Engl J Med 330:962–968,drial dysfunction, whatever its cause, and FSGS.
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